Evidence map›Paper›PMID 28540653›Full record

ReviewProtein & cell2018

IL-2 and IL-15 dependent thymic development of Foxp3-expressing regulatory T lymphocytes.

Cécile Apert, Paola Romagnoli, Joost P M van Meerwijk

Open access · diamondAbstract readReview
In one paragraph

Review in Protein & cell, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 35 citations in OpenAlex.

  1. Trial
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Differentiation and regulation of CD4Cellular and molecular life sciences : CMLS · 2024
    Review
  8. Lymphotoxin limits Foxp3Nature communications · 2024
    Article
  9. Review
  10. Review
  11. Review
  12. Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Future prospects for CD8Immunological reviews · 2019
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Cécile ApertCPTP, Université de Toulouse, CNRS, Inserm, UPS, Toulouse, France.
Paola RomagnoliCPTP, Université de Toulouse, CNRS, Inserm, UPS, Toulouse, France. Paola.Romagnoli@inserm.fr.
Joost P M van MeerwijkCPTP, Université de Toulouse, CNRS, Inserm, UPS, Toulouse, France. Joost.van-Meerwijk@inserm.fr.
Université Fédérale de Toulouse Midi-Pyrénées · FRCentre National de la Recherche Scientifique · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Immunosuppressive regulatory T lymphocytes (Treg) expressing the transcription factor Foxp3 play a vital role in the maintenance of tolerance of the immune-system to self and innocuous non-self. Most Treg that are critical for the maintenance of tolerance to self, develop as an independent T-cell lineage from common T cell precursors in the thymus. In this organ, their differentiation requires signals from the T cell receptor for antigen, from co-stimulatory molecules, as well as from cytokine-receptors. Here we focus on the cytokines implicated in thymic development of Treg, with a particular emphasis on the roles of interleukin-2 (IL-2) and IL-15. The more recently appreciated involvement of TGF-β in thymic Treg development is also briefly discussed. Finally, we discuss how cytokine-dependence of Treg development allows for temporal, quantitative, and potentially qualitative modulation of this process.

Indexed as

AnimalsCell DifferentiationCytokinesForkhead Transcription FactorsGene Expression RegulationImmune ToleranceInterleukin-15Interleukin-2MiceReceptors, Antigen, T-CellT-Lymphocytes, RegulatoryTransforming Growth Factor betaCytokinesForkhead Transcription FactorsFOXP3 protein, humanInterleukin-15Interleukin-2Receptors, Antigen, T-CellTransforming Growth Factor betadifferentiationIL-15IL-2regulatory T cellsthymus

Identifiers

PMID28540653
PMCPMC5876181
OpenAlexW2618977250

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.